Felecia Wimberly-Gibson
Adult Health · Streetsboro, OHNPI 1053730390
Payments from drug & device makers
Across 97 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$412
- Lilly USA, LLC$162
- Biohaven Pharmaceuticals, Inc.$151
- Novo Nordisk$111
- Amarin Pharma, Inc.$100
- AstraZeneca$99
- plus $436 from 11 others
What the payments were for
- Food & beverage$1,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $412 |
| Lilly USA, LLC | 12 | $162 |
| Biohaven Pharmaceuticals, Inc. | 12 | $151 |
| Novo Nordisk | 8 | $111 |
| Amarin Pharma, Inc. | 6 | $100 |
| AstraZeneca | 7 | $99 |
| Johnson & Johnson | 5 | $78 |
| Boehringer Ingelheim | 6 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $72 |
| Merck | 3 | $43 |
| GSK | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Bayer | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,470 in reported general payments places this provider in the 75th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 106 | $1,033 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $553 |
| Atorvastatin Calcium | 42 | $513 |
| Hydromorphone Hcl | 30 | $475 |
| Pantoprazole Sodium | 27 | $439 |
| Gabapentin | 40 | $435 |
| Levothyroxine Sodium | 43 | $373 |
| Metformin Hcl ErMetformin Hcl | 14 | $208 |
| Metoprolol Succinate | 14 | $200 |
| Rosuvastatin Calcium | 21 | $177 |
| Amlodipine Besylate | 36 | $176 |
| Losartan Potassium | 27 | $170 |
| Omeprazole | 22 | $151 |
| Cyclobenzaprine Hcl | 21 | $151 |
| Methadone Hcl | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Other adult health in Streetsboro
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
- Teresa ShafferBoardman$102K
- Jesse McClainYoungstown$79K
- Lucretia LongColumbus$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.